Intraretinal immunohistochemistry findings in proliferative vitreoretinopathy with retinal shortening

Ophthalmic Research

Volumn 38, Issue 4, 2006, Pages 193-200

  Pastor, J Carlos ^a   Méndez, M Carmen ^b   De La Fuente, Miguel A ^a   Coco, Rosa M ^a   García Arumí, José ^c   De La Rúa, Enrique Rodríguez ^a   Fernández, Nieves ^b   Saornil, M Antonia ^b   Gayoso, Manuel J ^b  

^a UNIVERSITY OF VALLADOLID   (Spain)

^b UNIVERSITY OF VALLADOLID   (Spain)

^c HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

Author keywords

Proliferative vitreoretinopathy; Retinal gliosis; Retinal shortening

Indexed keywords

CD68 ANTIGEN; CYTOKERATIN; GLIAL FIBRILLARY ACIDIC PROTEIN; VIMENTIN;

ADULT; AGED; ARTICLE; CELL HYPERPLASIA; CELL LOSS; CONTROLLED STUDY; ELECTRON MICROSCOPY; FEMALE; GLIOSIS; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INTERMEDIATE FILAMENT; MACROPHAGE; MALE; MUELLER CELL; PATHOGENESIS; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; RETINA DETACHMENT; VITREORETINOPATHY;

ADULT; AGED; ANTIGENS, CD; ANTIGENS, DIFFERENTIATION, MYELOMONOCYTIC; BIOLOGICAL MARKERS; FEMALE; GLIAL FIBRILLARY ACIDIC PROTEIN; GLIOSIS; HUMANS; IMMUNOHISTOCHEMISTRY; KERATINS; MALE; MICROSCOPY, ELECTRON; MIDDLE AGED; PROGNOSIS; RETINA; VITREORETINOPATHY, PROLIFERATIVE;

EID: 33747073771     PISSN: 00303747     EISSN: None     Source Type: Journal    
DOI: 10.1159/000093070     Document Type: Article

References (32)

1. The Retina Society Terminology Committee: The classification of retinal detachment with proliferative vitreoretinopathy. Ophthalmology 1983;90:121-125.
2. Wiedemann P, Weller M: The pathophysiology of proliferative vitreoretinopathy. Acta Ophthalmol Suppl 1988;189:7-15.
3. Pastor JC, Rodríguez de la Rúa E, Martín F: Proliferative vitreoretinopathy: risk factors and pathobiology. Prog Retin Eye Res 2002;21:127-144.
4. Lewis H, Aarberg TM: Anterior proliferative vitreoretinopathy. Am J Ophthalmol 1988;105:277-284.
5. Elner SG, Elner VM, Díaz-Rohena RR, Freeman HM, Tolentino FI, Albert DM: Anterior proliferative vitreoretinopathy. Clinico-pathologic, light microscopic, and ultrastructural findings. Ophthalmology 1988; 95: 1349-1357.
6. Stödtler M, Mietz H, Wiedemann P, Heimann K: Immunohistochemistry of anterior proliferative vitreoretinopathy. Int Ophthalmol 1994-5;18:323-328.
7. Pastor JC: Proliferative vitreoretinopathy: an overview. Surv Ophthalmol 1998;43:3-18.
8. Lean JS, Stern WH, Irvine AR, Azen SP: Classification of proliferative vitreoretinopathy used in the silicone study. The Silicone Study Group. Ophthalmology 1989;96:765-771.
9. Pastor JC, Rodríguez de la Rúa E, Martin F, Mayo-Iscar A, de la Fuente MA, Coco R, Bailez C, Mahave S: Retinal shortening: the most severe form of proliferative vitreoretinopathy (in Spanish). Arch Soc Esp Oftalmol 2003;8:653-657.
10. McGraw J, Hiebert GW, Steeves JD: Modulating astrogliosis after neurotrauma. J Neurosci Res 2001;63:109-115.
11. Guidry C: The role of Müller cells in fibrocontractive retinal disorders. Prog Retin Eye Res 2005;24:75-86.
12. Guidry C, Bradley KM, King JL: Tractional force generation by human Müller cells: growth factor responsiveness and integrin receptor involvement. Invest Ophthalmol Vis Sci 2003;44:1355-1363.
13. Dyer MA, Cepko CL: Control of Müller glial cell proliferation and activation following retinal injury. Nat Neurosci 2000;3:873-880.
14. Hogan MJ, Zimmerman LE: Ophthalmic Pathology, ed 2. Philadelphia, WB Saunders, 1962, p 90.
15. Fisher SK, Lewis GP: Müller cell and neuronal remodelling in retinal detachment and reattachment and their potential consequences for visual recovery: a review and reconsideration of recent data. Vision Res 2003;43:887-897.
16. Fisher SK, Lewis GP, Linberg KA, Verardo MR: Cellular remodelling in mammalian retina: results from studies of experimental retinal detachment. Prog Ret in Eye Res 2005;24:359-431.
17. Guerin CJ, Russell WW, Eifrig DE, Anderson DH: Immunocytochemical identification of Muller's glia as a component of human epiretinal membranes. Invest Ophthalmol Vis Sci 1990;31:1483-1491.
18. Heidenkummer HP, Kampik A: Proliferative activity and immunohistochemical cell differentiation in human epiretinal membranes. Ger J Ophthalmol 1992;1:170-175.
19. Morino I, Hiscott P, McKechnie N, Grierson I: Variation in epiretinal membrane components with clinical duration of the proliferative tissue. Br J Ophthalmol 1990;74:393-399.
20. Hiscott PS, Grierson I, Trombetta CJ, Rahi AH, Marshall J, McLeod D: Retinal and epiretinal glia - An immunohistochemical study. Br J Ophthalmol 1984;68:698-707.
21. Messmer EM, Heidenkummer HP, Kampik A: Ultrastructure of epiretinal membranes associated with macular holes. Graefes Arch Clin Exp Ophthalmol 1998;236:248-254.
22. Shinoda K, Hirakata A, Hida T, Yamaguchi Y, Fukuda M, Maekawa S, Azuma N: Ultrastructural and immunohistochemical findings in five patients with vitreomacular traction syndrome. Retina 2000;20:289-293.
23. Elner SG, Elner VM, Nielsen JC, Torczynski E, Yu R, Franklin WA: CD68 antigen expression by human retinal pigment epithelial cells. Exp Eye Res 1992;55:21-28.
24. Fuchs U, Kivela T, Tarkkanen A: Cytoskeleton in normal and reactive human retinal pigment epithelial cells. Invest Ophthalmol Vis Sci 1991;32:3178-3186.
25. Osusky R, Ryan SJ: Retinal pigment epithelial cell proliferation: potentiation by monocytes and serum. Graefes Arch Clin Exp Ophthalmol 1996;234(suppl 1):S76-S82.
26. Tang S, Scheiffarth OF, Wildner G, Thurau SR, Lund OE: Lymphocytes, macrophages and HLA-DR expression in vitreal and epiretinal membranes of proliferative vitreoretinopathy: an immunohistochemical study. Ger J Ophthalmol 1992;1:176-179.
27. Esser P, Heimann K, Wiedemann P: Macrophages in proliferative vitreoretinopathy and proliferative diabetic retinopathy: differentiation of subpopulations. Br J Ophthalmol 1993;77:731-733.
28. Kirchhof B, Sorgente N: Pathogenesis of proliferative vitreoretinopathy. Modulation of retinal pigment epithelial cell functions by vitreous and macrophages. Dev Ophthalmol 1989;16:1-53.
29. Osusky R, Malik P, Aurora Y, Ryan SJ: Monocyte-macrophage differentiation induced by coculture of retinal pigment epithelium cells with monocytes. Ophthalmic Res 1997;29:124-129.
30. Kirchhof B, Kirchhof E, Ryan SJ, Dixon JF, Barton BE, Sorgente N: Macrophage modulation of retinal pigment epithelial cell migration and proliferation. Graefes Arch Clin Exp Ophthalmol 1989;227:60-66.
31. Limb GA, Chignell AH, Woon H, Green W, Cole CJ, Dumonde DC: Evidence of chronic inflammation in retina excised after relaxing retinotomy for anterior proliferative vitreoretinopathy. Graefes Arch Clin Exp Ophthalmol 1996;234:213-220.
32. Sethi CS, Lewis GP, Fisher SK, Leitner WP, Mann DL, Luthert PJ, Charteris DG: Glial remodelling and neural plasticity in human retinal detachment with proliferative vitreoretinopathy. Invest Ophthalmol Vis Sci 2005;46:329-342.